CNBC Fast Money Podcast Summary

Episode: Looking Ahead To Fed Decision; Waystar CEO on AI in Health Care
Date: September 15, 2025
Host: Melissa Lee
Panel: Tim Seymour, Karen Fireman, Steve Grasso, Guy Adami

Episode Overview

This episode centers on major market-shaping issues: ongoing U.S.-China trade negotiations—especially the potential TikTok deal and its impact on Chinese and emerging market stocks—as well as milestones for major tech companies like Alphabet. Other key topics include Citi's surprising stock run, the uranium/nuclear energy boom, Novo Nordisk’s latest weight loss drug data, and Tesla’s continued rally following Elon Musk’s massive stock purchase. The episode is rich with tactical trading views, sector analysis, and lively trader banter.

Key Discussion Points & Insights

1. U.S.-China Trade Talks & Tech Stock Boom

[01:01-07:44]

Developments:

• Reports of a framework deal for TikTok between the U.S. and China—but key details (ownership, algorithm sale, buyer identity) remain unresolved ([02:44-04:22]).
• President Trump and Xi Jinping may hold a call Friday, possibly finalizing an agreement.
• Chinese tech stocks rally (KWEB ETF at 4-year highs, FXI breakout).

Skepticism & Analysis:

• Melissa Lee voices skepticism:

  "It doesn't sound like they've agreed to all that much. If at issue is still whether or not they're going to allow for the sale of the algorithm, that seems like a big potential stumbling block." ([04:22])

• Tim Seymour emphasizes the broader context:

  "It has set the backstage for two things driving outperformance for emerging markets and for China Tech, which include the Fed... A weaker dollar is great for EM." ([06:17])

Trading Take:

• Guy Adami: Alibaba and KWEB ETF are breaking out; "there's still further room to the upside." ([08:05])
• Karen Fireman: Current thawing of relations is bullish, especially for names like Alibaba and Nvidia.
• Steve Grasso: The current "framework" might just set up for another extension, keeping markets hopeful into November ([09:19]).

Notable Quotes:

• Tim Seymour:

  "US stocks have kind of forgotten about China… I think it's better for [Chinese stocks]." ([10:10])

• Steve Grasso:

  "China is reliant on this deal going through because you can make the case that China's economy is weaker right now than the US is." ([11:24])

2. Interview: Derek Irwin, Allspring Global

[12:24-17:02]

• Derek Irwin sees the Chinese market rally as powered more by pro-growth policies and the AI boom than headline trade progress alone ([12:50]).
• On risks:

  "I think the Russia issue is a big one and bigger than we think... We've moved from trade focus to the US trying to reorganize global trade systems to using tariffs and trade policy as a geopolitical tool." ([14:44])

• Stock Picks:
  • Top pick: Tencent ("as well positioned or maybe better than Alibaba" due to a powerful app ecosystem and AI leverage) ([15:38]).
  • "I think that both sides would really, really like to punt [the Taiwan question] as far down the road as they can." ([16:32])

3. Alphabet Joins the $3 Trillion Club

[19:02-21:30]

• Alphabet (Google) becomes the fourth company to top a $3 trillion market cap after a favorable antitrust ruling.
• Karen Fireman:

  "That run was really extraordinary... Google is in front on the AI, not behind, has also been very good." ([19:33])

• Steve Grasso:

  "There was a time when people were betting against the stock for so long, they were so surprised... I would sell it." ([21:03])

• Tim Seymour:

  "The antitrust result has unlocked value on the core businesses in a way that I don't think the street had predicted." ([20:29])

4. Citigroup Hits $100—Profit-Taking or More Room to Run?

[23:26-26:57]

• Citi shares hit $100 for the first time since pre-financial crisis; up 42% YTD.
• Guy Adami: Cautions that after such a move, “you have to do something here”—reducing exposure or taking partial profits ([23:56]).
• Karen Fireman: Still bullish but managing risk with options ("selling extra 1 tens," October expiration) ([25:27]).
• Steve Grasso:

  "If rates are cut, that's going to be a tailwind for financials... If we get nothing, I think the market craves this meeting at this meeting." ([26:21])

5. Uranium/Nuclear Energy Rally

[28:37-32:30]

• U.S. Energy Secretary signals plans to replenish uranium reserves and reduce reliance on Russian uranium.
• Tim Seymour:

  "Cameco themselves are adding to the frenzy here because they talked about a production shortfall. So, I mean, there’s such a squeeze going on… I think this is a place you want to still be." ([29:37])

• Guy Adami: Notes URA ETF still has upside; “the real problem is when everybody starts talking about it… is the time to fade it and look for better entry point.” ([30:52])
• Steve Grasso: Highlights rare bipartisan agreement for nuclear push.

Memorable Cultural Moment:

• Tim Seymour:

  "No Nukes was a big deal and now everybody wants nukes." ([32:07])

6. Novo Nordisk, Eli Lilly, and Weight Loss Drug Market

[33:01-35:29]

• Novo granted expanded cardiovascular approval for diabetes drug; its new GLP-1 trial showed significant efficacy but muted stock reaction.
• Karen Fireman: Surprised Novo didn’t bounce: “I would have thought actually… Novo so done so poorly this year and is so relatively inexpensive that it would have had a bigger jump.” ([33:45])
• Tim Seymour: “Novo really has the biggest market share… I like Novo. I’m long them both [Novo & Lilly]. I own more Novo than Lilly.” ([34:20])
• Guy Adami & Steve Grasso: Both see lack of technical excitement in the charts; “neither stock really shows any explosive ability to the upside.” ([35:10-35:29])

7. Tesla Surging After Elon Musk's $1 Billion Buy

[35:45-37:49]

• Musk purchases $1 billion in TSLA shares—the first open market buy since Feb 2020; stock pops 3.5%, now positive on the year.
• Steve Grasso:

  "There’s only one reason why [CEOs] buy stock, because they think the stock is going up." ([36:13])

• Guy Adami (with signature wit):

  "He knows probably better than anybody that if he's going to announce a billion dollar purchase, he's going to get that type of reaction in the stock. So it all makes sense." ([36:32])

• Tim Seymour:

  "I think sentiment in the stock's been awful… I'm not sure I even understand how to value it." ([37:26])

Notable Quotes & Moments

• Melissa Lee [04:22]: "Call me a skeptic, but it doesn't sound like they've agreed to all that much."
• Tim Seymour [06:17]: "It has set the backstage for two things: a weaker dollar is great for EM, and China Tech is investable again."
• Guy Adami [08:05]: "Alibaba... there's still further room to the upside."
• Derek Irwin [15:38]: "The other big elephant in China is Tencent… maybe better positioned than Alibaba as AI develops."
• Karen Fireman [19:33]: "Google is in front on the AI, not behind… which has been very good."
• Steve Grasso [36:13]: "There’s only one reason why they buy stock—because they think the stock is going up."
• Tim Seymour [32:07]: "No Nukes was a big deal and now everybody wants nukes."

Key Segment Timestamps

• U.S.-China/TikTok Framework News: 01:01–11:55
• Derek Irwin Interview: 12:24–17:02
• Alphabet $3 Trillion Club: 19:02–21:30
• Citi Profit-Taking and Analysis: 23:26–26:57
• Uranium/Nuclear Energy Boom: 28:37–32:30
• Novo Nordisk & Weight Loss Drugs: 33:01–35:29
• Tesla & Elon Musk Buy: 35:45–37:49

Final Trades

[38:16]

• Tim Seymour: "If you don’t like Baba, JD.com has not rallied as much and is cheaper."
• Karen Fireman: "Novo Nordisk—I think it is bottomed out."
• Steve Grasso: "Avis Budget—tailwind for them with rates going lower."
• Guy Adami: [Jokes about Peter Frampton, music; final picks not specified.]

Tone & Style

The episode featured the classic "Fast Money" brisk, unscripted, and trader-driven dialogue, mixing actionable ideas, sector rotation talk, technical levels, and frequent wit and banter among the panelists. The tone is engaging, practical, and occasionally irreverent—aimed squarely at investors who want both high-level insight and street-smart trade recommendations.